Stocks
Charles River Laboratories International () EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 21.5% | 26.3% | 23.2% | 24.8% | 25.0% | 24.8% | ||
| Changes by years, y/y, % | +3pp | +5pp | -3pp | +2pp | +0pp | +6.7% | |||
Charles River Laboratories International. EBITDA margin, %
Charles River Laboratories International. EBITDA margin, changes, pp
Charles River Laboratories International () EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | 23.6% | 22.8% | 22.0% | 31.8% | 22.6% | 24.8% | |
| Changes by years, y/y, % | +2pp | +4pp | +1pp | +3pp | -1pp | |||
| Changes by quarters, q/q, % | -5pp | -1pp | -1pp | +10pp | -9pp | |||
